Cancers (Jan 2023)

Cumulative UV Exposure or a Modified SCINEXA™-Skin Aging Score Do Not Play a Substantial Role in Predicting the Risk of Developing Keratinocyte Cancers after Solid Organ Transplantation—A Case Control Study

  • Liliane Borik-Heil,
  • Georg Endler,
  • Walther Parson,
  • Andreas Zuckermann,
  • Lisa Schnaller,
  • Keziban Uyanik-Ünal,
  • Peter Jaksch,
  • Georg Böhmig,
  • Daniel Cejka,
  • Katharina Staufer,
  • Elisabeth Hielle-Wittmann,
  • Susanne Rasoul-Rockenschaub,
  • Peter Wolf,
  • Raute Sunder-Plassmann,
  • Alexandra Geusau

DOI
https://doi.org/10.3390/cancers15030864
Journal volume & issue
Vol. 15, no. 3
p. 864

Abstract

Read online

The risk of keratinocyte cancer is determined by intrinsic and extrinsic factors, which also influence skin aging. Few studies have linked skin aging and UV exposure with the incidence of non-melanoma skin cancer (NMSC). We evaluated signs of actinic skin damage and aging, individual UV burden, and melanocortin-1 receptor (MC1R) variants. A total of 194 organ transplant recipients (OTR) who suffered from NMSC were compared to 194 tumor-free controls matched for gender, age, type of transplanted organ, post-transplantation (TX) period, and immunosuppressive therapy. Compared with the cases, the controls scored higher in all skin aging scores and there were no differences in UV burden except for intentional whole-body UV exposure for specific UV scenarios and periods of life in favor of cases. The number of NMSCs correlated with all types of skin aging scores, the extent of intentional sun exposure, older age, longer post-TX period, shorter interval from TX to first NMSC, and specific MC1R risk groups. Multivariable models revealed a 7.5-fold risk of developing NMSC in individuals with actinic keratosis; 4.1- or 3.6-fold in those with green or blue eyes, respectively; and a 1.9-fold increased risk in the MC1R medium- + high-risk group. In the absence of skin aging contributing to NMSC development, certain MC1R risk types may identify OTR at risk for high tumor burden.

Keywords